Researchers at the University of Wisconsin-Madison have found a new way to accelerate a workhorse instrument that identifies proteins. The high-speed technique could help diagnose cancer sooner and point to new drugs for treating a wide range of conditions.
In efforts to understand what influences life span, cancer and aging, scientists are building road maps to navigate and learn about cells at the molecular level.
Parallel reaction monitoring (PRM) – based targeted mass spectrometry is comparable in performance to selected reaction monitoring (SRM) but requires much less investment in assay development for targeted proteomics applications.
Josh Coon’s work has weight. It’s right there in the name: mass spectrometry. It’s there in the results, too, enabling science by giving researchers an ever-sharper understanding of the molecules that make up living things.
© 2019 Coon Research Group. - All Rights Reserved. | Privacy Policy